Posts

Showing posts from June, 2024

IB Net Payout Yields Model

Carnival: Set To Cruise Back Up (Rating Upgrade)

Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Update - June 24, 2024 Carnival reported a h uge quarter with massive cash flows. Not sure why the market got so negative on the stock, but the cruise line is now far more profitable than thought. The  $17 stock likely has earnings power of up to $2 in a few years.  -Q2 Non-GAAP EPS of $0.11 beats by $0.13. -Revenue of $5.78B (+17.7% Y/Y) beats by $90M. -Total customer deposits reached an all-time high of $8.3 billion, surpassing the previous record by $1.1 billion ($7.2 billion as of May 31, 2023). Original article posted on May 13, 2024 Carnival Corporation & plc stock has trended down to $14, providing an opportunity for investors to buy back in. The upcoming August quarter is expected to bring strong earnings finally for Carnival, with a quarterly profit topping $1 per share. Carnival's positive cash flows will help bo...

Novavax: New Chapter, Questions Remain

  Novavax, Inc. secured a lucrative deal with Sanofi, receiving potentially $1.2 billion in cash and future royalties for Covid vaccines. The deal significantly improved Novavax's financial position, but the stock has already rallied from $4 to $14, limiting potential upside. Novavax's future success hinges on the royalty revenue from the Sanofi deal in 2025, with limited ability to compete with Sanofi's commercialization capabilities. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » In a matter of months,  Novavax, Inc.  ( NASDAQ: NVAX ) went from a biotech with a questionable future to one flush with cash and a potentially huge royalty deal. Investors being too greedy and not alert were probably caught  on the wrong side of the trade. My  investment thesis  is more Neutral on the biotech due to the stock now trading at nearly $14, up from only $4. Read ...

Celsius: Unaltered Growth Story

Image
Updated - June 12 Celsius continues to collapse due to Pepsi optimizing inventory levels. Pepsi cut inventory levels by another $20 to $30 million in Q2 following $20 million in Q1 for a total of up to $50 million. The stock has now fallen from $100 to only $62 and lily on the path to the previous lows at $50.  Celsius Holdings ( NASDAQ: CELH ) is on watch after several analysts lowered Q2 estimates on the energy drink company due in part to further inventory reduction by PepsiCo ( PEP ). During an investor conference on Tuesday, Celsius Holdings ( CELH ) management quantified the  PepsiCo ( PEP ) inventory reduction during the quarter at $20 million to $30 million sequentially, which came on the heels of a $20 million inventory reduction in Q1. "While some of the reduction was driven by PEP's working capital efficiencies and CELH starting to ship more to PEP's smaller distribution warehouses vs larger mixing centers, we believe the bulk of the 1H inventory cut reflects th...